RNG in Stage 2 Uptrend, 7 of 8 Trend Checks Passed near 52-Week Highs

RNG stock profile infographic with daily candles, 20, 50 and 150-day simple moving averages and volume, Stage 2 (Advancing), as of October 23, 2026 at 13:53 - CANSLIM Research
RNG is trading at 79.42, holding above a rising 30-week moving average in a confirmed Stage 2 advance and sitting just 2.7 percent off its 52-week high. The stock passes 7 of 8 trend template checks, with the only miss being the relative strength line not yet at a three-month high, and no formal base or VCP has formed given the brief one-week consolidation. Sentiment reads bullish, with the offensive setup intact and the 81.62 pivot level the key breakout reference to watch.

RNG   Daily · data to 2026-10-22 close · 20 SMA 50 SMA 150 SMA
Frozen at publication – this chart does not move. Open live chart on TradingView →

SECTORTechnologyINDUSTRYSoftware – Application
Stage 2Weinstein stage
Data to US close: Thu 22 Oct 2026 16:00 ET = Fri 23 Oct 2026 04:00 HKT
Created: Fri 23 Oct 2026 13:53 HKT = Fri 23 Oct 2026 01:53 ET

Inside the Full Report

  • 🔒
    Stage AnalysisWhy the stock sits in this stage and what would change that
  • 🔒
    Detected PatternsWhich setups the scan found, with buy point and failure level
  • 🔒
    Trend Template: All 8 ChecksWhich criteria pass, which fail, and by how much
  • 🔒
    Fundamental SnapshotGrowth, margins, valuation and the earnings date


Disclaimer: This report is for informational and educational purposes only and does not constitute investment advice. Figures come from the scanned result (as of October 23, 2026) and company filings; all estimates not explicitly sourced from the provided data are clearly labeled as such. The analysis may contain errors — always verify against primary filings (10-K/10-Q/8-K) before making any investment decision.

About CANSLIM Research

CANSLIM Research is an independent project using AI to analyze global financial data by applying rule-based algorithms derived from well-known momentum traders. Our AI personas—simulations inspired by these methods with no trader affiliation or endorsement—scan stocks, analyze charts, track sector rotation, and publish educational insights under human oversight. Support via contributions, sponsorship, or partnership never buys stock-specific access, influences publishing, or involves paid security features. We are not a registered charity.

Disclaimer: All content is strictly educational—not investment advice, recommendations, or buy/sell solicitations. CANSLIM Research is not a licensed adviser or analyst under any regulatory body (including SEC, FINRA, SFC, FCA, SEBI, or EU authorities under ESMA). Investing carries risk of total loss, and past performance does not predict future results. Consult a licensed financial adviser before investing.